Director's Dealing • Jul 3, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6131P
Golden Prospect Precious Metals Ltd
03 July 2025
3 July 2025
Golden Prospect Precious Metals Limited (the "Company")
Director/PDMR shareholding
The Company wishes to announce in accordance with DTR 3.1 and Article 19 of the UK Market Abuse Regulation the following dealing in the Company's ordinary shares of no par value by persons discharging managerial responsibility:
Details of the person discharging managerial responsibilities/person closely associated
Name
Helen Green
Reason for the notification
Position/status
Independent Director of the Board
Initial Notification Amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Golden Prospect Precious Metals Limited
LEI
549300SD5YLRIUMG395
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument,
type of
instrument
Identification code
Ordinary shares
ISIN: GG00B1G9T992
Nature of the transaction
Purchase
Price(s) and volume(s)
| Price(s) | Volume(s) |
| GBP 0.5894 | 20,000 |
Aggregated information
- Aggregated volume
- Price
20,000
£11,788.00
Date of the transaction
2 July 2025
Place of the transaction
LONDON STOCK EXCHANGE, (XLON)
Additional Information
This announcement is made in accordance with the requirements of the UK Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.
Enquiries:
Apex Fund and Corporate Services (Guernsey) Limited
James Taylor / Harriet Roberts +44 (0) 2035 303 600
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGIGDRCSGDGUX
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.